Data as of 1:50pm ET
| -0.27 / -2.37%|
The 6 analysts offering 12-month price forecasts for Raptor Pharmaceutical Corp have a median target of 17.50, with a high estimate of 33.00 and a low estimate of 7.00. The median estimate represents a +57.52% increase from the last price of 11.11.
The current consensus among 6 polled investment analysts is to Buy stock in Raptor Pharmaceutical Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.